http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 30 Apr 2025 16:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Press+Releases/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html <p align="justify">TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=MSAV6awRWAxV81vkMX5iBs0brA0bJXghd-4bhc9G7h4Or6Az8oTIjGqP8LLon76YxK5dyzZlW4EB4VWUX32vU1wxzaWYPTU-_maUl13TgJU=" rel="nofollow" target="_blank">Profound Medical Corp.</a> (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 2025 Bloom Burton &amp; Co. Healthcare Investor Conference on Tuesday, May 6, 2025 at 1:30 p.m. Eastern Time at the Metro Toronto Convention Centre.</p> <p align="justify">The presentation will be broadcast live and archived on the Company&apos;s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=BIXwMtoakM8RLBYllL46c-GYJOS5kY7mLNHhhaCW5tAARFEqHBvep3uA7TvHjYrYuuZf7MJ5o2Z3WG1IDjENTLmoVWb5vllER8ntaKAlwy0=" rel="nofollow" target="_blank">www.profoundmedical.com</a> under http://www.streetinsider.com/Globe+Newswire/Profound+Medical+to+Participate+in+the+2025+Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference/24719095.html Wed, 30 Apr 2025 16:30:00 -0400 A.06822034 A.17150087 A.50208689 O.19076731 O.20026344 O.49223070 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html <p align="center"><em>BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR</em></p> <p align="justify">TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the pricing of an underwritten public offering (the “Offering”) of 4,666,700 common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The gross proceeds of the Offering to Profound, before deducting the underwriting discounts and commissions and other offering expenses payable by Profound, are expected to be approximately US$35 http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html Fri, 06 Dec 2024 09:04:00 -0400 A.02062790 A.05289004 A.09642568 A.21446405 A.26391080 O.00003925 O.00030728 O.03096051 O.19076731 O.19742033 O.20371933 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html <p align="center"><em>BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR</em></p> <p align="justify">TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the pricing of an underwritten public offering (the “Offering”) of 4,666,700 common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The gross proceeds of the Offering to Profound, before deducting the underwriting discounts and commissions and other offering expenses payable by Profound, are expected to be approximately US$35 http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html Fri, 06 Dec 2024 09:04:00 -0400 A.02062790 A.05289004 A.09642568 A.21446405 A.26391080 O.00003925 O.00030728 O.03096051 O.19076731 O.19742033 O.20371933 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html <p align="center"><em>BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR</em></p> <p align="justify">TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the pricing of an underwritten public offering (the “Offering”) of 4,666,700 common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The gross proceeds of the Offering to Profound, before deducting the underwriting discounts and commissions and other offering expenses payable by Profound, are expected to be approximately US$35 http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html Fri, 06 Dec 2024 09:04:00 -0400 A.02062790 A.05289004 A.09642568 A.21446405 A.26391080 O.00003925 O.00030728 O.03096051 O.19076731 O.19742033 O.20371933 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html <p align="center"><em>BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR</em></p> <p align="justify">TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the pricing of an underwritten public offering (the “Offering”) of 4,666,700 common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The gross proceeds of the Offering to Profound, before deducting the underwriting discounts and commissions and other offering expenses payable by Profound, are expected to be approximately US$35 http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html Fri, 06 Dec 2024 09:04:00 -0400 A.02062790 A.05289004 A.09642568 A.21446405 A.26391080 O.00003925 O.00030728 O.03096051 O.19076731 O.19742033 O.20371933 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html <p align="center"><em>BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR</em></p> <p align="justify">TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the pricing of an underwritten public offering (the “Offering”) of 4,666,700 common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The gross proceeds of the Offering to Profound, before deducting the underwriting discounts and commissions and other offering expenses payable by Profound, are expected to be approximately US$35 http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html Fri, 06 Dec 2024 09:04:00 -0400 A.02062790 A.05289004 A.09642568 A.21446405 A.26391080 O.00003925 O.00030728 O.03096051 O.19076731 O.19742033 O.20371933 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html <p align="center"><em>BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR</em></p> <p align="justify">TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the pricing of an underwritten public offering (the “Offering”) of 4,666,700 common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The gross proceeds of the Offering to Profound, before deducting the underwriting discounts and commissions and other offering expenses payable by Profound, are expected to be approximately US$35 http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html Fri, 06 Dec 2024 09:04:00 -0400 A.02062790 A.05289004 A.09642568 A.21446405 A.26391080 O.00003925 O.00030728 O.03096051 O.19076731 O.19742033 O.20371933 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html <p align="center"><em>BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR</em></p> <p align="justify">TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the pricing of an underwritten public offering (the “Offering”) of 4,666,700 common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The gross proceeds of the Offering to Profound, before deducting the underwriting discounts and commissions and other offering expenses payable by Profound, are expected to be approximately US$35 http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html Fri, 06 Dec 2024 09:04:00 -0400 A.02062790 A.05289004 A.09642568 A.21446405 A.26391080 O.00003925 O.00030728 O.03096051 O.19076731 O.19742033 O.20371933 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html <p align="center"><em>BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR</em></p> <p align="justify">TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the pricing of an underwritten public offering (the “Offering”) of 4,666,700 common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The gross proceeds of the Offering to Profound, before deducting the underwriting discounts and commissions and other offering expenses payable by Profound, are expected to be approximately US$35 http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html Fri, 06 Dec 2024 09:04:00 -0400 A.02062790 A.05289004 A.09642568 A.21446405 A.26391080 O.00003925 O.00030728 O.03096051 O.19076731 O.19742033 O.20371933 PRN PROF http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html <p align="center"><em>BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR</em></p> <p align="justify">TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the pricing of an underwritten public offering (the “Offering”) of 4,666,700 common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The gross proceeds of the Offering to Profound, before deducting the underwriting discounts and commissions and other offering expenses payable by Profound, are expected to be approximately US$35 http://www.streetinsider.com/Press+Releases/Profound+Medical+Announces+Pricing+of+US%2435+Million+Underwritten+Public+Offering+of+Common+Shares/24074985.html Fri, 06 Dec 2024 09:04:00 -0400 A.02062790 A.05289004 A.09642568 A.21446405 A.26391080 O.00003925 O.00030728 O.03096051 O.19076731 O.19742033 O.20371933 PRN PROF